Literature DB >> 871619

Recurrent massive haemorrhage from benign hepatic tumours secondary to oral contraceptives.

N N Bein, H S Goldsmith.   

Abstract

Liver cell adenoma as a cause of spontaneous haemoperitoneum has been noted with increasing frequency since Baum's initial report (Baum et al., 1973). The relationship between the use of oral contraceptives and bleeding from a hepatic tumour makes awareness of this condition mandatory for the physician involved in the differential diagnosis of the acute abdomen. The report presented here is that of a woman who, while taking oral contraceptives, subsequently bled from her liver 3 years after an initial hepatic haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871619     DOI: 10.1002/bjs.1800640616

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Tyrosine aminotransferase contributes to benzylisoquinoline alkaloid biosynthesis in opium poppy.

Authors:  Eun-Jeong Lee; Peter J Facchini
Journal:  Plant Physiol       Date:  2011-09-23       Impact factor: 8.340

2.  Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit.

Authors:  Nicola de'Angelis; Riccardo Memeo; Julien Calderaro; Emanuele Felli; Chady Salloum; Philippe Compagnon; Alain Luciani; Alexis Laurent; Daniel Cherqui; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2014-05-23       Impact factor: 3.647

Review 3.  Review of general surgery 1977.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1978-06       Impact factor: 2.401

4.  Tyrosine aminotransferase: biochemical and structural properties and molecular dynamics simulations.

Authors:  Prajwalini Mehere; Qian Han; Justin A Lemkul; Christopher J Vavricka; Howard Robinson; David R Bevan; Jianyong Li
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

5.  Liver cell adenoma and liver cell adenomatosis.

Authors:  Ludger Barthelmes; Iain S Tait
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.